Perrigo | PRGO - 普通股股本

金融业

USD 16.02

USD 7.61B

现金及等价物

USD 357.2M

USD 708.9M

USD 2.45B

USD 1.05B

USD 3.63B

股息收益率

12.17

USD 33.6M

USD 141.6M

8.38K

EPS每股收益

USD 0.5

股本和储备

USD 2.52B

USD 313.9M

债务利息支出

USD 7.61B

USD 3.28B

USD 2.17B

USD 74.5M

USD 290.5M

USD 23.5M

普通股股本

USD 138.1M

27.45

USD 105.4M

USD 1.02B

销售和管理费用

USD 3.28B

USD 1.06B

贸易债权人

USD 400.4M

应收帐款人

USD 697.1M

	普通股股本	更改		日
AbbVie	USD 1.77B		608K	2026-06
Abbott	USD 1.74B		2.94M	2026-03
Bayer	EUR 982.42M		0	2026-06
Bristol-Myers Squibb	USD 2.04B		7M	2026-06
Coherus Biosciences	USD 121.16M		4.92M	2025-12
Corcept Therapeutics	USD 107.33M		1.36M	2026-03
Dr.Reddys Laboratories	INR 833.07M		382K	2026-09
Eli Lilly	USD 943.5M		3.33M	2026-03
J&J	USD 2.41B		1.64M	2026-06
Merck	USD 2.47B		1.05M	2026-06
Nestle	CHF 2.57B		0	2026-06
Pacira	USD 39.82M		512K	2026-06
Perrigo	USD 138.1M		500K	2026-03
Pfizer	USD 5.7B		0	2026-06
Phibro Animal Health	USD 40.48M		0	2025-12
Prestige Brands	USD 47.37M		53K	2026-06
Reckitt Benckiser	GBP 679.21M		605.21M	2025-06
Sanofi	EUR 1.2B		10.77M	2026-06
Supernus Pharmaceuticals	USD 58.16M		124K	2026-06
Teva Pharmaceutical Industries	USD 1.16B		1000K	2026-06
Xeris Pharmaceuticals	USD 172.56M		6.34M	2026-03
Zoetis	USD 414.15M		6.19M	2026-06